Evidence map›Paper›PMID 25880591›Full record

ArticleMolecular cancer2015

Host and tumor derived MMP13 regulate extravasation and establishment of colorectal metastases in the liver.

Alisha M Mendonsa, Michael N VanSaun, Alessandro Ustione, David W Piston, Barbara M Fingleton, David Lee Gorden

Open access · goldAbstract read
In one paragraph

Article in Molecular cancer, 2015. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 34 papers.

0numbers the graph read from it
0cells of the map it votes in
34citing papers in PubMed
1.9field-weighted citation impact, top 15% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

34 citing papers in PubMed, 53 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Review
  11. Article
  12. Article
  13. Analysis of the prognostic value of uric acid on the efficacy of immunotherapy in patients with primary liver cancer.Clinical & translational oncology : official publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico · 2024
    Article
  14. Article
  15. Article
  16. Review
  17. Article
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 1 institution in 1 country.

Alisha M MendonsaDepartment of Cancer Biology, Vanderbilt University, 2220 Pierce Ave S, Nashville, TN, 37232, USA. alisha.m.mendonsa@vanderbilt.edu.
Michael N VanSaunDepartment of Cancer Biology, Vanderbilt University, 2220 Pierce Ave S, Nashville, TN, 37232, USA. michael.n.vansaun@vanderbilt.edu.
Alessandro UstioneDepartment of Molecular Physiology and Biophysics, Vanderbilt University, 702 Light Hall 21st Avenue South, Nashville, TN, 37232, USA. alessandro.ustione@vanderbilt.edu.
David W PistonDepartment of Molecular Physiology and Biophysics, Vanderbilt University, 702 Light Hall 21st Avenue South, Nashville, TN, 37232, USA. dave.piston@vanderbilt.edu.
Barbara M FingletonDepartment of Cancer Biology, Vanderbilt University, 2220 Pierce Ave S, Nashville, TN, 37232, USA. barbara.fingleton@vanderbilt.edu.
David Lee GordenDepartment of Cancer Biology, Vanderbilt University, 2220 Pierce Ave S, Nashville, TN, 37232, USA. lee.gorden@vanderbilt.edu.
Vanderbilt University · US

Funding

Molecular Determinants of Tumor Progression in A Steatolic Liver MicroenvironmentU01CA143072 · NCI · VANDERBILT UNIVERSITY · PI GORDEN, DAVID L, MOSES, HAROLD L · 2009 to 2013
$1.4M
NCI NIH HHS 5U01CA143072NCI NIH HHS U01 CA143072
6 · The paper itself

Abstract

backgroundNon alcoholic fatty liver disease (NAFLD) is one of the most common liver diseases in the United States and worldwide. Our studies have previously shown an increase in metastatic burden in steatotic vs. normal livers using a mouse model of diet induced steatosis. In the present study we aim to identify and evaluate the molecular factors responsible for this increase in tumor burden.

methodsWe assessed changes in expression of a panel of matrix metalloproteinases (MMPs) using qRT-PCR between normal and steatotic livers and validated them with western blot analysis of protein levels. To evaluate the role of MMP13 on tumor development, we utilized a splenic injection model of liver metastasis in Wildtype and Mmp13 deficient mice, using either parental or stable Mmp13 knockdown cell lines. Further, to evaluate changes in the ability of tumor cells to extravasate we utilized whole organ confocal microscopy to identify individual tumor cells relative to the vasculature. MTT, migration and invasion assays were performed to evaluate the role of tumor derived MMP13 on hallmarks of cancer in vitro.

resultsWe found that MMP13 was significantly upregulated in the steatotic liver both in mice as well as human patients with NAFLD. We showed a decrease in metastatic tumor burden in Mmp13-/- mice compared to wildtype mice, explained in part by a reduction in the number of tumor cells extravasating from the hepatic vasculature in the Mmp13-/- mice compared to wildtype mice. Additionally, loss of tumor derived MMP13 through stable knockdown in tumor cell lines lead to decreased migratory and invasive properties in vitro and metastatic burden in vivo.

conclusionsThis study demonstrates that stromal as well as tumor derived MMP13 contribute to tumor cell extravasation and establishment of metastases in the liver microenvironment.

Indexed as

AnimalsCell MovementColorectal NeoplasmsDisease Models, AnimalFatty LiverGene ExpressionHumansLiver NeoplasmsMaleMatrix Metalloproteinase 13MiceMice, KnockoutNeoplasm InvasivenessStromal CellsMatrix Metalloproteinase 13

Identifiers

PMID25880591
PMCPMC4351934
OpenAlexW2169744880

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.